Cheng Du Sheng Nuo Biotec Co. Ltd. A
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company offers semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide,… Read more
Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.021x
Based on the latest financial reports, Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) has a cash flow conversion efficiency ratio of -0.021x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-21.56 Million) by net assets (CN¥1.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cheng Du Sheng Nuo Biotec Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Cheng Du Sheng Nuo Biotec Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cheng Du Sheng Nuo Biotec Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cheng Du Sheng Nuo Biotec Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
0.019x |
|
Lee and Man Paper Manufacturing Limited
F:LMP
|
0.029x |
|
TOYO ENGINEERG-6330-
F:6AE
|
N/A |
|
SCHOTT Pharma AG & Co. KGaA
XETRA:1SXP
|
0.096x |
|
Fukuyama Transporting Co. Ltd
F:FUY
|
N/A |
|
Beijing Chieftain Control Engineering Technology Co Ltd
SHE:300430
|
-0.034x |
|
Anterix Inc
NASDAQ:ATEX
|
-0.035x |
|
Revenio Group Corporation
HE:REG1V
|
0.064x |
Annual Cash Flow Conversion Efficiency for Cheng Du Sheng Nuo Biotec Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Cheng Du Sheng Nuo Biotec Co. Ltd. A from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥918.32 Million | CN¥25.27 Million | 0.028x | -72.01% |
| 2023-12-31 | CN¥880.10 Million | CN¥86.53 Million | 0.098x | -14.99% |
| 2022-12-31 | CN¥826.74 Million | CN¥95.62 Million | 0.116x | +73.26% |
| 2021-12-31 | CN¥785.14 Million | CN¥52.41 Million | 0.067x | -63.87% |
| 2020-12-31 | CN¥437.57 Million | CN¥80.84 Million | 0.185x | +124.95% |
| 2019-12-31 | CN¥376.46 Million | CN¥30.92 Million | 0.082x | -59.40% |
| 2018-12-31 | CN¥327.35 Million | CN¥66.23 Million | 0.202x | -16.00% |
| 2017-12-31 | CN¥241.74 Million | CN¥58.22 Million | 0.241x | -- |